e study is to find discontinuations due to the adverse events and serious adverse events that occur during the clinical trials. The secondary outcome measures include finding PANSS and cognitive assessment test scores at 12 week period.
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=88a244d1-eddb-499c-bee2-e1f49056e78f |
